We are live on
!
Find out more
GGHC
Gilder Gagnon Howe & Co Portfolio holdings
AUM
$9.69B
1-Year Est. Return
55.7%
This Fund
S&P 500
This Quarter
Est. Return
+16.73%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$7.31B
AUM Growth
+$1.27B
(+21%)
Cap. Flow
+$483M
Cap. Flow
% of AUM
6.6%
Top 10 Holdings %
Top 10 Hldgs %
32.03%
Holding
355
New
109
Increased
77
Reduced
150
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Datadog
DDOG
|
+$69.4M |
| 2 |
Roblox
RBLX
|
+$67M |
| 3 |
Adobe
ADBE
|
+$48.4M |
| 4 |
Arista Networks
ANET
|
+$47.4M |
| 5 |
EPAM Systems
EPAM
|
+$29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Repligen
RGEN
|
+$30M |
| 2 |
Mobileye
MBLY
|
+$26.6M |
| 3 |
Calix
CALX
|
+$15.7M |
| 4 |
HubSpot
HUBS
|
+$15.7M |
| 5 |
DEN
Denbury Inc.
DEN
|
+$15.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.88% |
| 2 | Consumer Discretionary | 19.89% |
| 3 | Healthcare | 16.44% |
| 4 | Communication Services | 10% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Compass
COMP
$7.95B
| $166K | ﹤0.01% |
47,326
| – | – |
|
252
Asana
ASAN
$2.18B
| $157K | ﹤0.01% |
+7,109
| New | +$142K |
|
253
Tidewater
TDW
$4.57B
| $156K | ﹤0.01% |
+2,818
| New | +$129K |
|
254
Group 1 Automotive
GPI
$3.28B
| $156K | ﹤0.01% |
+603
| New | +$139K |
|
255
Lockheed Martin
LMT
$123B
| $148K | ﹤0.01% |
+322
| New | +$149K |
|
|
NVTA
256
DELISTED
Invitae Corporation
NVTA
| $113K | ﹤0.01% |
99,869
-511,169
| -84% | -$645K |
|
257
Affirm
AFRM
$24.3B
| $95.2K | ﹤0.01% |
+6,211
| New | +$82.4K |
|
258
Safety Insurance
SAFT
$1.52B
| $91K | ﹤0.01% |
+1,269
| New | +$92.8K |
|
259
CoreCivic
CXW
$3.5B
| $76K | ﹤0.01% |
+8,079
| New | +$73.3K |
|
|
NVEE
260
DELISTED
NV5 Global
NVEE
| $71.3K | ﹤0.01% |
+2,576
| New | +$63.2K |
|
261
Treace Medical Concepts
TMCI
$298M
| $69.3K | ﹤0.01% |
+2,708
| New | +$69.9K |
|
262
Tandem Diabetes Care
TNDM
$1.13B
| $66.5K | ﹤0.01% |
+2,710
| New | +$87.2K |
|
263
Rivian
RIVN
$22.5B
| $48K | ﹤0.01% |
2,884
-16,337
| -85% | -$228K |
|
264
Lyft
LYFT
$5.94B
| $46.4K | ﹤0.01% |
+4,835
| New | +$46.5K |
|
265
Valens Semiconductor
VLN
$172M
| $34.7K | ﹤0.01% |
+13,724
| New | +$34.9K |
|
|
266
Mobileye
MBLY
$6.73B
| $32.2K | ﹤0.01% |
838
-656,696
| -100% | -$26.6M |
|
267
STAAR Surgical
STAA
$1.13B
| $30.2K | ﹤0.01% |
+574
| New | +$35K |
|
268
Accel Entertainment
ACEL
$938M
| $25.3K | ﹤0.01% |
+2,400
| New | +$22.5K |
|
269
Applied Materials
AMAT
$334B
| $24.3K | ﹤0.01% |
168
-4,897
| -97% | -$613K |
|
270
FIGS
FIGS
$2.21B
| $23.5K | ﹤0.01% |
+2,844
| New | +$21.6K |
|
271
Palantir
PLTR
$415B
| $22.4K | ﹤0.01% |
+1,462
| New | +$16.6K |
|
272
Franklin Covey
FC
$203M
| $16.8K | ﹤0.01% |
+385
| New | +$14.3K |
|
273
Generac Holdings
GNRC
$10.3B
| $15.4K | ﹤0.01% |
+103
| New | +$11.7K |
|
274
Ford
F
$53.8B
| $14.9K | ﹤0.01% |
+986
| New | +$12.5K |
|
275
Guardant Health
GH
$23.6B
| $13K | ﹤0.01% |
+363
| New | +$10.4K |
|
Similar funds
SC
AV
FIA
OAM
DM
PVI
HTC
Gilder Gagnon Howe & Co's Q2 2023 Portfolio in Review
As of Q2 2023, Gilder Gagnon Howe & Co held 355 positions worth $7.31B, up 21% from $6.04B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Gilder Gagnon Howe & Co deployed $483M of net new capital in Q2 2023, opening 109 new positions and adding to 77 existing holdings. Its largest new stake was Intel: 532,525 shares worth $17.8M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Repligen, an estimated $30M trimmed.
- Gilder Gagnon Howe & Co's largest Q2 2023 buy was Intel: 532,525 shares worth $17.8M.
- Gilder Gagnon Howe & Co added most to Datadog in Q2 2023, an estimated $69.4M increase.
- Gilder Gagnon Howe & Co's biggest Q2 2023 reduction was Repligen, cutting an estimated $30M.
- Gilder Gagnon Howe & Co fully exited Apollo Endosurgery, Inc. in Q2 2023, selling an estimated $3.69M.
- Gilder Gagnon Howe & Co's ten largest holdings make up 32% of its $7.31B portfolio in Q2 2023.
- Gilder Gagnon Howe & Co opened 109 new positions and closed 13 in Q2 2023.
- Gilder Gagnon Howe & Co's portfolio value rose 21% quarter-over-quarter to $7.31B.
Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2023, filed 14 Aug 2023.